2015-2027 Global Neuroprotection Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 126 pages | ID: 2489637229AAEN
Maia Research

Abstracts

The worldwide market for Neuroprotection is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Allergan
AstraZeneca
Biogen
Daiichi Sankyo Company
Dr. Reddy’s Laboratories
F. Hoffmann-La Roche
Astrocyte Pharmaceuticals
Novartis
Eli Lilly and Company
Teva Pharmaceutical

Major Types Covered
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others

Major Applications Covered
Prevention
Treatment

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Neuroprotection Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Neuroprotection Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE NEUROPROTECTION MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL NEUROPROTECTION MARKET-SEGMENTATION BY TYPE

5.1 Free Radical Trapping Agents (Antioxidants)
5.2 Glutamate Antagonists (Anti-Excitotoxic Agents)
5.3 Apoptosis Inhibitors
5.4 Anti-inflammatory Agents
5.5 Neurotrophic Factors (NTFs)
5.6 Metal Ion Chelators
5.7 Stimulants
5.8 Others

6 GLOBAL NEUROPROTECTION MARKET-SEGMENTATION BY APPLICATION

6.1 Prevention
6.2 Treatment

7 GLOBAL NEUROPROTECTION MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Allergan
  8.1.1 Allergan Profile
  8.1.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Allergan Product/Solution Launches and Enhancements Analysis
  8.1.4 Allergan Business Overview/Recent Development/Acquisitions
8.2 AstraZeneca
  8.2.1 AstraZeneca Profile
  8.2.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
  8.2.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.3 Biogen
  8.3.1 Biogen Profile
  8.3.2 Biogen Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Biogen Product/Solution Launches and Enhancements Analysis
  8.3.4 Biogen Business Overview/Recent Development/Acquisitions
8.4 Daiichi Sankyo Company
  8.4.1 Daiichi Sankyo Company Profile
  8.4.2 Daiichi Sankyo Company Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Daiichi Sankyo Company Product/Solution Launches and Enhancements Analysis
  8.4.4 Daiichi Sankyo Company Business Overview/Recent Development/Acquisitions
8.5 Dr. Reddy’s Laboratories
  8.5.1 Dr. Reddy’s Laboratories Profile
  8.5.2 Dr. Reddy’s Laboratories Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Dr. Reddy’s Laboratories Product/Solution Launches and Enhancements Analysis
  8.5.4 Dr. Reddy’s Laboratories Business Overview/Recent Development/Acquisitions
8.6 F. Hoffmann-La Roche
  8.6.1 F. Hoffmann-La Roche Profile
  8.6.2 F. Hoffmann-La Roche Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 F. Hoffmann-La Roche Product/Solution Launches and Enhancements Analysis
  8.6.4 F. Hoffmann-La Roche Business Overview/Recent Development/Acquisitions
8.7 Astrocyte Pharmaceuticals
  8.7.1 Astrocyte Pharmaceuticals Profile
  8.7.2 Astrocyte Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Astrocyte Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.7.4 Astrocyte Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.8 Novartis
  8.8.1 Novartis Profile
  8.8.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.8.4 Novartis Business Overview/Recent Development/Acquisitions
8.9 Eli Lilly and Company
  8.9.1 Eli Lilly and Company Profile
  8.9.2 Eli Lilly and Company Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Eli Lilly and Company Product/Solution Launches and Enhancements Analysis
  8.9.4 Eli Lilly and Company Business Overview/Recent Development/Acquisitions
8.10 Teva Pharmaceutical
  8.10.1 Teva Pharmaceutical Profile
  8.10.2 Teva Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Teva Pharmaceutical Product/Solution Launches and Enhancements Analysis
  8.10.4 Teva Pharmaceutical Business Overview/Recent Development/Acquisitions

9 GLOBAL NEUROPROTECTION MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Neuroprotection Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Neuroprotection Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Neuroprotection Production Analysis from 2015-2020
10.4 North America Neuroprotection Consumption Analysis from 2015-2020
10.5 North America Neuroprotection Import and Export from 2015-2020
10.6 North America Neuroprotection Value, Production and Market Share by Type (2015-2020)
10.7 North America Neuroprotection Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Neuroprotection by Country (United States, Canada)
  10.8.1 North America Neuroprotection Sales by Country (2015-2020)
  10.8.2 North America Neuroprotection Consumption Value by Country (2015-2020)
10.9 North America Neuroprotection Market PEST Analysis

11 EUROPE

11.1 Europe Neuroprotection Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Neuroprotection Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Neuroprotection Production Analysis from 2015-2020
11.4 Europe Neuroprotection Consumption Analysis from 2015-2020
11.5 Europe Neuroprotection Import and Export from 2015-2020
11.6 Europe Neuroprotection Value, Production and Market Share by Type (2015-2020)
11.7 Europe Neuroprotection Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Neuroprotection by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Neuroprotection Sales by Country (2015-2020)
  11.8.2 Europe Neuroprotection Consumption Value by Country (2015-2020)
11.9 Europe Neuroprotection Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Neuroprotection Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Neuroprotection Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Neuroprotection Production Analysis from 2015-2020
12.4 Asia-Pacific Neuroprotection Consumption Analysis from 2015-2020
12.5 Asia-Pacific Neuroprotection Import and Export from 2015-2020
12.6 Asia-Pacific Neuroprotection Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Neuroprotection Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Neuroprotection by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Neuroprotection Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Neuroprotection Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Neuroprotection Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Neuroprotection Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Neuroprotection Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Neuroprotection Production Analysis from 2015-2020
13.4 Latin America Neuroprotection Consumption Analysis from 2015-2020
13.5 Latin America Neuroprotection Import and Export from 2015-2020
13.6 Latin America Neuroprotection Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Neuroprotection Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Neuroprotection by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Neuroprotection Sales by Country (2015-2020)
  13.8.2 Latin America Neuroprotection Consumption Value by Country (2015-2020)
13.9 Latin America Neuroprotection Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Neuroprotection Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Neuroprotection Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Neuroprotection Production Analysis from 2015-2020
14.4 Middle East & Africa Neuroprotection Consumption Analysis from 2015-2020
14.5 Middle East & Africa Neuroprotection Import and Export from 2015-2020
14.6 Middle East & Africa Neuroprotection Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Neuroprotection Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Neuroprotection by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Neuroprotection Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Neuroprotection Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Neuroprotection Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL NEUROPROTECTION MARKET FROM 2020-2027

15.1 Future Forecast of the Global Neuroprotection Market from 2020-2027 Segment by Region
15.2 Global Neuroprotection Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Neuroprotection Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Neuroprotection Market Value ($) and Growth Rate of Neuroprotection from 2015-2027
Global Neuroprotection Production and Growth Rate Segment by Product Type from 2015-2027
Global Neuroprotection Consumption and Growth Rate Segment by Application from 2015-2027
Figure Neuroprotection Picture
Table Product Specifications of Neuroprotection
Table Driving Factors for this Market
Table Industry News of Neuroprotection Market
Figure Value Chain Status of Neuroprotection
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Neuroprotection Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Neuroprotection Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Free Radical Trapping Agents (Antioxidants) of Neuroprotection
Figure Glutamate Antagonists (Anti-Excitotoxic Agents) of Neuroprotection
Figure Apoptosis Inhibitors of Neuroprotection
Figure Anti-inflammatory Agents of Neuroprotection
Figure Neurotrophic Factors (NTFs) of Neuroprotection
Figure Metal Ion Chelators of Neuroprotection
Figure Stimulants of Neuroprotection
Figure Others of Neuroprotection
Table Global Neuroprotection Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Neuroprotection Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Prevention of Neuroprotection
Figure Treatment of Neuroprotection
Table Global Neuroprotection Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Neuroprotection Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Neuroprotection
Figure Online Channel of Neuroprotection
Table Allergan Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan Sales and Growth Rate from 2015-2020
Figure Allergan Revenue ($) and Global Market Share from 2015-2020
Table Allergan Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Biogen Profile (Company Name, Plants Distribution, Sales Region)
Figure Biogen Sales and Growth Rate from 2015-2020
Figure Biogen Revenue ($) and Global Market Share from 2015-2020
Table Biogen Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Daiichi Sankyo Company Profile (Company Name, Plants Distribution, Sales Region)
Figure Daiichi Sankyo Company Sales and Growth Rate from 2015-2020
Figure Daiichi Sankyo Company Revenue ($) and Global Market Share from 2015-2020
Table Daiichi Sankyo Company Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Dr. Reddy’s Laboratories Profile (Company Name, Plants Distribution, Sales Region)
Figure Dr. Reddy’s Laboratories Sales and Growth Rate from 2015-2020
Figure Dr. Reddy’s Laboratories Revenue ($) and Global Market Share from 2015-2020
Table Dr. Reddy’s Laboratories Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table F. Hoffmann-La Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure F. Hoffmann-La Roche Sales and Growth Rate from 2015-2020
Figure F. Hoffmann-La Roche Revenue ($) and Global Market Share from 2015-2020
Table F. Hoffmann-La Roche Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Astrocyte Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Astrocyte Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Astrocyte Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Astrocyte Pharmaceuticals Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly and Company Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly and Company Sales and Growth Rate from 2015-2020
Figure Eli Lilly and Company Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly and Company Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Teva Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region)
Figure Teva Pharmaceutical Sales and Growth Rate from 2015-2020
Figure Teva Pharmaceutical Revenue ($) and Global Market Share from 2015-2020
Table Teva Pharmaceutical Neuroprotection Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Neuroprotection Production Value ($) by Region from 2015-2020
Table Global Neuroprotection Production Value Share by Region from 2015-2020
Table Global Neuroprotection Production by Region from 2015-2020
Table Global Neuroprotection Consumption Value ($) by Region from 2015-2020
Table Global Neuroprotection Consumption by Region from 2015-2020
Table North America Neuroprotection Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Neuroprotection Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Neuroprotection Import and Export from 2015-2020
Table North America Neuroprotection Value ($) by Type (2015-2020)
Table North America Neuroprotection Production by Type (2015-2020)
Table North America Neuroprotection Consumption by Application (2015-2020)
Table North America Neuroprotection Consumption by Country (2015-2020)
Table North America Neuroprotection Consumption Value ($) by Country (2015-2020)
Figure North America Neuroprotection Market PEST Analysis
Table Europe Neuroprotection Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Neuroprotection Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Neuroprotection Import and Export from 2015-2020
Table Europe Neuroprotection Value ($) by Type (2015-2020)
Table Europe Neuroprotection Production by Type (2015-2020)
Table Europe Neuroprotection Consumption by Application (2015-2020)
Table Europe Neuroprotection Consumption by Country (2015-2020)
Table Europe Neuroprotection Consumption Value ($) by Country (2015-2020)
Figure Europe Neuroprotection Market PEST Analysis
Table Asia-Pacific Neuroprotection Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Neuroprotection Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Neuroprotection Import and Export from 2015-2020
Table Asia-Pacific Neuroprotection Value ($) by Type (2015-2020)
Table Asia-Pacific Neuroprotection Production by Type (2015-2020)
Table Asia-Pacific Neuroprotection Consumption by Application (2015-2020)
Table Asia-Pacific Neuroprotection Consumption by Country (2015-2020)
Table Asia-Pacific Neuroprotection Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Neuroprotection Market PEST Analysis
Table Latin America Neuroprotection Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Neuroprotection Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Neuroprotection Import and Export from 2015-2020
Table Latin America Neuroprotection Value ($) by Type (2015-2020)
Table Latin America Neuroprotection Production by Type (2015-2020)
Table Latin America Neuroprotection Consumption by Application (2015-2020)
Table Latin America Neuroprotection Consumption by Country (2015-2020)
Table Latin America Neuroprotection Consumption Value ($) by Country (2015-2020)
Figure Latin America Neuroprotection Market PEST Analysis
Table Middle East & Africa Neuroprotection Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Neuroprotection Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Neuroprotection Import and Export from 2015-2020
Table Middle East & Africa Neuroprotection Value ($) by Type (2015-2020)
Table Middle East & Africa Neuroprotection Production by Type (2015-2020)
Table Middle East & Africa Neuroprotection Consumption by Application (2015-2020)
Table Middle East & Africa Neuroprotection Consumption by Country (2015-2020)
Table Middle East & Africa Neuroprotection Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Neuroprotection Market PEST Analysis
Table Global Neuroprotection Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Neuroprotection Production and Growth Rate Forecast by Region (2020-2027)
Table Global Neuroprotection Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Neuroprotection Production and Growth Rate Forecast by Type (2020-2027)
Table Global Neuroprotection Consumption and Growth Rate Forecast by Application (2020-2027)